The future is now: AI-enabled RNA–LNP discovery

“I think we will see the emergence of LNPs targeted to the lung and the brain, as well as to immune cells.”Charlotte Barker, Commissioning Editor, Vaccine Insights, talks with Bowen Li, Assistant Professor at the University of Toronto, about how his groundbreaking work with the AI-driven LUMI-lab platform is delivering a new generation of LNPs with unique capabilities.